How Long Does It Take for Zepbound to Work?

Appetite changes come first, measurable weight loss follows within the first 3 months for most people, and the largest losses build through month 18. This table lines up the milestones reported in the label and in trial analyses.

The week 12 and week 24 figures come from post hoc analyses of trial data, which are exploratory. They describe groups, not what any one person will see.

Zepbound starts working on appetite within the first weeks. In a 6-week trial of 114 adults without diabetes, tirzepatide cut energy intake at an all-you-can-eat lunch by about 525 kcal compared with placebo at week 3.3 The same trial found lower overall appetite, fewer food cravings and less perceived hunger with tirzepatide than with placebo.3

The label explains part of the early effect. Tirzepatide slows how fast the stomach empties, and that delay is largest after the first dose and shrinks over time.1 That is why the first weeks can feel very different from month six.

For most trial participants, appetite changes appeared within weeks, as measured at week 3 in the phase 1 trial.3 The size of the effect varies from person to person, and the starting dose of 2.5 mg is not meant to be a treatment dose.1

The first 4 weeks are on 2.5 mg, a dose the label calls a starting dose, not a maintenance dose.1 The dose then steps up by 2.5 mg after at least 4 weeks on each dose.1 At the fastest pace, a person reaches 15 mg in week 21.1

Two things drive the slow start:

• Dose. In the main trial, weight loss rose with dose: 15.0% on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg at week 72.1
• Time. Steady blood levels take 4 weeks of weekly dosing to build.1

The step-up is deliberate. Most nausea, vomiting and diarrhea in the trials happened during dose escalation and decreased over time.1 See our Zepbound dosage guide for the full schedule.

In SURMOUNT-1, 82% of participants who took their doses as scheduled lost at least 5% of their body weight by week 12.4 The analysis included 1,545 people treated with tirzepatide who received at least 75% of their assigned doses.4

The other 18% were labeled late responders.4 They were not non-responders:

• 70% of late responders reached 5% weight loss by week 24.4
• 90% reached 5% by week 72.4
• The mean time to 5% weight loss for late responders was 24.8 weeks.4

A second analysis used week 8 as the cutoff and found that both early and slower responders reached clinically meaningful weight reduction by week 72, although early responders lost more.5 Its authors noted the timing and severity of stomach side effects were similar between the groups.5

Late responders in SURMOUNT-1 were more likely to be male and started at a higher average weight.4 If the scale is slow in the first months, our guide to not losing weight on a GLP-1 covers the reasons the label and trials point to.

Tirzepatide behaves the same way whether it is sold as Zepbound or Mounjaro: steady levels after 4 weeks of weekly dosing and a half-life of about 5 days.2 Mounjaro also starts at 2.5 mg and rises in 2.5 mg steps.2

What differs is the goal. Mounjaro is approved for blood sugar control in type 2 diabetes, and its monotherapy trial measured the main result, the change in HbA1c, after 40 weeks.2 Our Mounjaro vs Zepbound comparison covers the other differences.

Compounded tirzepatide is a different case. The FDA does not review compounded drugs for safety, effectiveness or quality before they are sold, so the timelines above come from trials of the brand-name drug and may not carry over.7 See compounded tirzepatide vs Zepbound, and if you are weighing pharmacy-made vials, our ranking of compounded tirzepatide programs.

No. In the main trial, 9.1% of people on the 15 mg dose did not reach 5% weight loss by week 72.1 The rates of reaching at least 5% loss were 85.1% on 5 mg, 88.9% on 10 mg and 90.9% on 15 mg, against 34.5% on placebo.1

Results were lower in adults with type 2 diabetes. In that trial, average loss at week 72 was 12.8% on 10 mg and 14.7% on 15 mg.1 The label leaves the maintenance dose to the prescriber, based on response and tolerability.1 Our weight loss projection tool applies the trial averages to a starting weight.

Does Zepbound work right away? Tirzepatide is in the blood within hours and peaks a median of 24 hours after the dose.1 Measurable weight loss takes longer: most adherent trial participants had lost 5% by week 12.4

How soon does Zepbound start working for sleep apnea? The label's sleep apnea trials measured their main results at week 52, and the label lists 10 mg or 15 mg as the maintenance doses for that use.1 See our guide to Zepbound for sleep apnea.

Why do I feel the effect wear off before my next dose? The label does not describe a fading effect within a week. It does report that the slowing of stomach emptying is largest after the first dose and lessens over time.1 Talk to your prescriber if appetite changes concern you.

Does Zepbound work better than Wegovy? In SURMOUNT-5, a head-to-head trial, 44% of tirzepatide participants lost at least 15% by week 24, against 21% of semaglutide participants.6 Our Wegovy vs Zepbound comparison has the full results, and how long Wegovy takes to work covers its timeline.

What if I miss a dose? Take it within 4 days (96 hours). If more than 4 days have passed, skip it and take the next dose on your usual day.1 Our missed dose tool works out the timing.

Because results build over many months, the monthly cost matters as much as the first dose. Our Zepbound cost guide shows the price by dose and format, and our cheapest Zepbound options ranks where to buy it. For what the first month feels like, read your first weeks on a GLP-1.

This article is for information only and is not medical advice. Zepbound is a prescription drug with real risks and side effects. Talk to your prescriber before starting, changing or stopping any dose.